Opella Ernest was appointed Director of Privia Health Group, Inc., effective September 1, 2026. As of November 6, 2026, Privia Health Group, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from July 7, 2026 to August 18, 2026, naming 2 appointments and 1 departure (Form 8-K, August 18, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Privia Health Group, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Privia Health Group, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-07 to 2026-08-18. They name 2 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Privia Health Group, Inc. files it.
Also on the record for Privia Health Group, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.09% of the class | 5%+ stakes | Source |
| October 7, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 5% of the class | 5%+ stakes | Source |
| September 8, 2026 | Stake report, Schedule 13D, by Adam Boehler | 5.07% of the class | 5%+ stakes | Source |
| July 29, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 14.2% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.16% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| November 5, 2025 | Stake report, Schedule 13G/A, by FMR LLC | 10.1% of the class | 5%+ stakes | Source |
| October 24, 2025 | Stake report, Schedule 13G/A, by Puma Growth Holdings, LLC | 4.7% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G, by Puma Growth Holdings, LLC | 5.14% of the class | 5%+ stakes | Source |
| August 6, 2025 | Stake report, Schedule 13G/A, by FMR LLC | 11.4% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Privia Health Group, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Privia Health Group, Inc. and the records around it.
Privia Health Group, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- Puma Growth Holdings, LLC also filed stake reports on 1 other company: Evolent Health (Nov 2025)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
Watch Privia Health Group, Inc.
Get an email when Privia Health Group, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Privia Health Group, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Privia Health Group, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Privia Health Group, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-18 | In | Director | 2026-09-01 | 8-K, 2026-08-18 | |
| 2026-08-18 | In | 2026-09-01 | 8-K, 2026-08-18 | ||
| 2026-07-07 | Out | Director | 8-K, 2026-07-07 |
Who leads Privia Health Group, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Opella Ernest, appointed, effective 2026-09-01 (filed 2026-08-18).
New leaders reset buying decisions — get the Full Report on Privia Health Group, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Privia Health Group, Inc., with the record behind each one.
Find candidates like Director at Privia Health Group, Inc.Every change, in the filing's words
Appointed: Opella Ernest, Director, effective 2026-09-01
On August 12, 2026, the Board of Directors (the "Board") of Privia Health Group, Inc. (the "Company") elected Opella Ernest, M.D. to the Board as a Class III director, effective September 1, 2026.
Appointed: Opella Ernest, effective 2026-09-01
The Board also appointed Dr. Ernest as a member of the Compliance Committee of the Board effective September 1, 2026.
- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- The Board has determined Dr. Ernest to be independent in accordance with the independence standards of the rules of The Nasdaq Stock Market.
- Consistent with the terms of the Director Compensation Program, Dr. Ernest will also receive an annual equity grant, pursuant to the 2021 Omnibus Incentive Plan, as amended, of restricted stock units with a grant date fair market value of $200,000.
- Dr. Ernest will receive an initial grant pro-rated for the number of months that she will serve on the Board through the date of the next annual meeting of stockholders.
- The terms and conditions of these grants will be governed by an agreement substantially in the form of the Company's Form of 2021 Omnibus Plan Restricted Stock Unit Award for Non-Employee Directors.
- On August 18, 2026, the Company issued a press release announcing the election of Dr. Ernest to the Board.
Departing: Shawn Morris, Director
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the "Board") of Privia Health Group, Inc. (the "Company") and as a member of the Compliance Committee of the Board, effective immediately.
- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- Mr. Morris's resignation was not due to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- The Company and the Board express their sincere gratitude to Mr. Morris for his dedicated service, valuable insights, and contributions to the Company during his tenure.
Tools for this story
Each opens in a new tab, filled in for Privia Health Group, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.